Submit Manuscript  

Article Details


Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report

[ Vol. 19 , Issue. 3 ]

Author(s):

Gianfranco Calogiuri*, Eustachio Nettis, Alessandro Mandurino-Mirizzi, Elisabetta Di Leo, Luigi Macchia, Caterina Foti, Angelo Vacca and Nicholas G. Kounis   Pages 335 - 339 ( 5 )

Abstract:


The anti-IgE Omalizumab may be helpful to treat clopidogrel hypersensitivity without stopping thienopyridine administration in patients requirining continuous antiplatellet therapy after coronary stent placement.

Keywords:

Clopidogrel, omalizumab, prasugrel, thienopyridines, ticagrelor, urticaria.

Affiliation:

Pneumology and Allergy Department, Civil Hospital "Sacro Cuore" Gallipoli, Lecce, Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Cardiology Department, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Section of Allergy and Clinical Immunology, Unit of Internal Medicine-"F. Miulli" Hospital, Acquaviva Delle Fonti, Bari, Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Department of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari, 70124 Bari, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine, University of Bari "Aldo Moro" Medical School, Bari, Department of Cardiology, University of Patras Medical School, Patras



Read Full-Text article